Cargando…
Novel Liver-targeted conjugates of Glycogen Phosphorylase Inhibitor PSN-357 for the Treatment of Diabetes: Design, Synthesis, Pharmacokinetic and Pharmacological Evaluations
PSN-357, an effective glycogen phosphorylase (GP) inhibitor for the treatment for type 2 diabetics, is hampered in its clinical use by the poor selectivity between the GP isoforms in liver and in skeletal muscle. In this study, by the introduction of cholic acid, 9 novel potent and liver-targeted co...
Autores principales: | Zhang, Liying, Song, Chengjun, Miao, Guangxin, Zhao, Lianzhi, Yan, Zhiwei, Li, Jing, Wang, Youde |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5320518/ https://www.ncbi.nlm.nih.gov/pubmed/28225016 http://dx.doi.org/10.1038/srep42251 |
Ejemplares similares
-
Design, Synthesis, and Use of Novel Photoaffinity Probes in Measuring the Serum Concentration of Glycogen Phosphorylase
por: Zhang, Yuchao, et al.
Publicado: (2019) -
A Novel 5-Chloro-N-phenyl-1H-indole-2-carboxamide Derivative as Brain-Type Glycogen Phosphorylase Inhibitor: Validation of Target PYGB
por: Huang, Yatao, et al.
Publicado: (2023) -
Design, Synthesis, and Biological Application of Novel Photoaffinity Probes of Dihydropyridine Derivatives, BAY R3401
por: Zhang, Liying, et al.
Publicado: (2019) -
A Novel 5-Chloro-N-phenyl-1H-indole-2-carboxamide Derivative as Brain-Type Glycogen Phosphorylase Inhibitor: Potential Therapeutic Effect on Cerebral Ischemia
por: Huang, Yatao, et al.
Publicado: (2022) -
Manipulating the Expression of Glycogen Phosphorylase in Synechococcus elongatus PCC 7942 to Mobilize Glycogen Storage for Sucrose Synthesis
por: Dan, Yu, et al.
Publicado: (2022)